Regulation of proline biosynthesis: The inhibition of pyrroline-5-carboxylate synthase activity by ornithine

Ronna F. Lodato, Robert J. Smith, David Valle, James M. Phang, Thomas T. Aoki

Research output: Contribution to journalArticle

Abstract

Mammalian cells have the capacity for proline biosynthesis from ornithine or glutamic acid. Using a radioisotopic assay, we have studied the regulation by ornithine of Δ1-pyrroline-5-carboxylate synthase, the enzyme that catalyzes the first step of proline biosynthesis from glutamic acid. In homogenates from Chinese hamster ovary cells, ornithine was found to be a potent inhibitor of pyrroline-5-carboxylate synthase activity (50% inhibition at 0.37 mM). The effect was reversible and did not occur with amino acids other than ornithine. Preliminary findings suggest that the inhibition does not result from altered requirements for the cofactors NADPH and ATP. Significant inhibition was observed in four different Chinese hamster cell lines. Ornithine was also shown to inhibit the conversion of 3H-glutamic acid to 3H-proline in intact human skin fibroblasts. Cells from patients with a rare ocular disease, gyrate atrophy of the choroid and retina, were used for these studies since they lack interfering ornithine aminotransferase activity. We conclude that ornithine may be a physiologic regulator of the rate of proline formation from glutamic acid. This information allows us to construct an hypothetical model for the overall regulation of proline biosynthesis and also to suggest a pathophysiologic mechanism for the disease gyrate atrophy.

Original languageEnglish (US)
Pages (from-to)908-913
Number of pages6
JournalMetabolism
Volume30
Issue number9
DOIs
StatePublished - 1981

Fingerprint

Ornithine-Oxo-Acid Transaminase
Ornithine
Proline
Glutamic Acid
Gyrate Atrophy
Cricetulus
Eye Diseases
Rare Diseases
NADP
Ovary
Fibroblasts
Adenosine Triphosphate
Amino Acids
Cell Line
Skin
Enzymes

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Regulation of proline biosynthesis : The inhibition of pyrroline-5-carboxylate synthase activity by ornithine. / Lodato, Ronna F.; Smith, Robert J.; Valle, David; Phang, James M.; Aoki, Thomas T.

In: Metabolism, Vol. 30, No. 9, 1981, p. 908-913.

Research output: Contribution to journalArticle

Lodato, Ronna F. ; Smith, Robert J. ; Valle, David ; Phang, James M. ; Aoki, Thomas T. / Regulation of proline biosynthesis : The inhibition of pyrroline-5-carboxylate synthase activity by ornithine. In: Metabolism. 1981 ; Vol. 30, No. 9. pp. 908-913.
@article{dfaeb3a43eaf429c8cc7fea56c0e5068,
title = "Regulation of proline biosynthesis: The inhibition of pyrroline-5-carboxylate synthase activity by ornithine",
abstract = "Mammalian cells have the capacity for proline biosynthesis from ornithine or glutamic acid. Using a radioisotopic assay, we have studied the regulation by ornithine of Δ1-pyrroline-5-carboxylate synthase, the enzyme that catalyzes the first step of proline biosynthesis from glutamic acid. In homogenates from Chinese hamster ovary cells, ornithine was found to be a potent inhibitor of pyrroline-5-carboxylate synthase activity (50{\%} inhibition at 0.37 mM). The effect was reversible and did not occur with amino acids other than ornithine. Preliminary findings suggest that the inhibition does not result from altered requirements for the cofactors NADPH and ATP. Significant inhibition was observed in four different Chinese hamster cell lines. Ornithine was also shown to inhibit the conversion of 3H-glutamic acid to 3H-proline in intact human skin fibroblasts. Cells from patients with a rare ocular disease, gyrate atrophy of the choroid and retina, were used for these studies since they lack interfering ornithine aminotransferase activity. We conclude that ornithine may be a physiologic regulator of the rate of proline formation from glutamic acid. This information allows us to construct an hypothetical model for the overall regulation of proline biosynthesis and also to suggest a pathophysiologic mechanism for the disease gyrate atrophy.",
author = "Lodato, {Ronna F.} and Smith, {Robert J.} and David Valle and Phang, {James M.} and Aoki, {Thomas T.}",
year = "1981",
doi = "10.1016/0026-0495(81)90070-6",
language = "English (US)",
volume = "30",
pages = "908--913",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Regulation of proline biosynthesis

T2 - The inhibition of pyrroline-5-carboxylate synthase activity by ornithine

AU - Lodato, Ronna F.

AU - Smith, Robert J.

AU - Valle, David

AU - Phang, James M.

AU - Aoki, Thomas T.

PY - 1981

Y1 - 1981

N2 - Mammalian cells have the capacity for proline biosynthesis from ornithine or glutamic acid. Using a radioisotopic assay, we have studied the regulation by ornithine of Δ1-pyrroline-5-carboxylate synthase, the enzyme that catalyzes the first step of proline biosynthesis from glutamic acid. In homogenates from Chinese hamster ovary cells, ornithine was found to be a potent inhibitor of pyrroline-5-carboxylate synthase activity (50% inhibition at 0.37 mM). The effect was reversible and did not occur with amino acids other than ornithine. Preliminary findings suggest that the inhibition does not result from altered requirements for the cofactors NADPH and ATP. Significant inhibition was observed in four different Chinese hamster cell lines. Ornithine was also shown to inhibit the conversion of 3H-glutamic acid to 3H-proline in intact human skin fibroblasts. Cells from patients with a rare ocular disease, gyrate atrophy of the choroid and retina, were used for these studies since they lack interfering ornithine aminotransferase activity. We conclude that ornithine may be a physiologic regulator of the rate of proline formation from glutamic acid. This information allows us to construct an hypothetical model for the overall regulation of proline biosynthesis and also to suggest a pathophysiologic mechanism for the disease gyrate atrophy.

AB - Mammalian cells have the capacity for proline biosynthesis from ornithine or glutamic acid. Using a radioisotopic assay, we have studied the regulation by ornithine of Δ1-pyrroline-5-carboxylate synthase, the enzyme that catalyzes the first step of proline biosynthesis from glutamic acid. In homogenates from Chinese hamster ovary cells, ornithine was found to be a potent inhibitor of pyrroline-5-carboxylate synthase activity (50% inhibition at 0.37 mM). The effect was reversible and did not occur with amino acids other than ornithine. Preliminary findings suggest that the inhibition does not result from altered requirements for the cofactors NADPH and ATP. Significant inhibition was observed in four different Chinese hamster cell lines. Ornithine was also shown to inhibit the conversion of 3H-glutamic acid to 3H-proline in intact human skin fibroblasts. Cells from patients with a rare ocular disease, gyrate atrophy of the choroid and retina, were used for these studies since they lack interfering ornithine aminotransferase activity. We conclude that ornithine may be a physiologic regulator of the rate of proline formation from glutamic acid. This information allows us to construct an hypothetical model for the overall regulation of proline biosynthesis and also to suggest a pathophysiologic mechanism for the disease gyrate atrophy.

UR - http://www.scopus.com/inward/record.url?scp=0019418347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019418347&partnerID=8YFLogxK

U2 - 10.1016/0026-0495(81)90070-6

DO - 10.1016/0026-0495(81)90070-6

M3 - Article

C2 - 6115302

AN - SCOPUS:0019418347

VL - 30

SP - 908

EP - 913

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 9

ER -